| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.05 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |